Total Payments
$5,213
2024 Payments
$2,106
Companies
49
Transactions
239
Medicare Patients
1,102
Medicare Billing
$72,279
Payment Breakdown by Category
Food & Beverage$4,925 (94.5%)
Education$287.99 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,925 | 236 | 94.5% |
| Education | $287.99 | 3 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $371.47 | 20 | $0 (2024) |
| Genentech USA, Inc. | $339.24 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $329.29 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $286.01 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $270.51 | 11 | $0 (2024) |
| Incyte Corporation | $241.47 | 8 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $219.60 | 8 | $0 (2024) |
| Seagen Inc. | $209.05 | 8 | $0 (2023) |
| Eisai Inc. | $206.69 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $182.41 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,106 | 96 | Merck Sharp & Dohme LLC ($172.94) |
| 2023 | $2,346 | 112 | Takeda Pharmaceuticals U.S.A., Inc. ($198.63) |
| 2022 | $610.79 | 29 | Takeda Pharmaceuticals U.S.A., Inc. ($60.31) |
| 2021 | $150.41 | 2 | Seagen Inc. ($99.00) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Oncology | ||||||
| 12/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Oncology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Oncology | ||||||
| 12/05/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $24.54 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: BioOncology | ||||||
| 11/20/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Oncology | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/14/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/05/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Immunology | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/11/2024 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: BioOncology | ||||||
| 10/11/2024 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: BioOncology | ||||||
| 10/10/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 400 | 577 | $42,162 | $14,697 |
| 2022 | 2 | 163 | 229 | $36,246 | $12,213 |
| 2021 | 2 | 264 | 480 | $73,554 | $26,160 |
| 2020 | 3 | 275 | 519 | $66,089 | $19,209 |
Total Patients
1,102
Total Services
1,805
Medicare Billing
$72,279
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 71 | $13,401 | $5,408 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $15,675 | $5,152 | 32.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 50 | 100 | $1,540 | $795.95 | 51.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 49 | 90 | $2,379 | $665.11 | 28.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 27 | 47 | $2,178 | $616.56 | 28.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 34 | 42 | $1,487 | $434.70 | 29.2% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 20 | 28 | $1,111 | $350.00 | 31.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 20 | 22 | $1,128 | $325.16 | 28.8% |
| 83540 | Iron level | Office | 2023 | 28 | 48 | $1,057 | $298.93 | 28.3% |
| 82746 | Folic acid level, serum | Office | 2023 | 15 | 17 | $850.51 | $244.97 | 28.8% |
| 84165 | Protein measurement, serum | Office | 2023 | 13 | 16 | $592.00 | $168.48 | 28.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 22 | 28 | $561.40 | $165.76 | 29.5% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 13 | 13 | $201.50 | $70.98 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 111 | 169 | $29,406 | $10,025 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 60 | $6,840 | $2,188 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 155 | 324 | $55,938 | $20,215 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 109 | 156 | $17,616 | $5,945 | 33.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 193 | 381 | $42,306 | $12,257 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 71 | 127 | $21,582 | $6,487 | 30.1% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 11 | 11 | $2,201 | $465.16 | 21.1% |
About Kodi Bone, PA-C
Kodi Bone, PA-C is a Physician Assistant healthcare provider based in Ludington, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184886012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kodi Bone, PA-C has received a total of $5,213 in payments from pharmaceutical and medical device companies, with $2,106 received in 2024. These payments were reported across 239 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($4,925).
As a Medicare-enrolled provider, Bone has provided services to 1,102 Medicare beneficiaries, totaling 1,805 services with total Medicare billing of $72,279. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Ludington, MI
- Active Since 07/01/2008
- Last Updated 06/24/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1184886012
Products in Payments
- KEYTRUDA (Biological) $240.73
- Lenvima (Drug) $206.69
- ZEPZELCA (Drug) $195.59
- JAKAFI (Drug) $152.47
- XPOVIO (Drug) $128.71
- KISQALI (Drug) $127.94
- CALQUENCE (Drug) $122.09
- Fabhalta (Drug) $112.33
- Enhertu (Drug) $110.48
- Venclexta (Biological) $106.99
- ENHERTU (Biological) $102.99
- VERZENIO (Drug) $101.38
- ERLEADA (Drug) $100.19
- BOSULIF (Drug) $98.47
- BRUKINSA (Drug) $97.16
- SARCLISA (Biological) $94.64
- AVASTIN (Drug) $91.70
- Tazverik (Drug) $89.51
- BESREMI (Drug) $80.47
- Columvi (Biological) $74.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ludington
Nicole Tompkins, Pa, PA
Physician Assistant — Payments: $654.42
Physician Assistant $654.42
Brent Johnson, Pa, PA
Physician Assistant — Payments: $416.78
Physician Assistant $416.78
Susan Persson, Pa C, PA C
Physician Assistant — Payments: $287.59
Physician Assistant $287.59
Ashleigh Graham, Pa, PA
Physician Assistant — Payments: $181.12
Physician Assistant $181.12
Alexander Warnsholz, Pa-C, PA-C
Physician Assistant — Payments: $170.95
Physician Assistant $170.95
Ms. Monica Hagen, Pa-C, PA-C
Physician Assistant — Payments: $160.42
Physician Assistant $160.42